Related Experiment Video
Updated: Jul 4, 2025

12:18
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
Published on: January 11, 2020
7.5K
Medical aid in dying to avoid late-stage dementia
Thaddeus Mason Pope1, Lisa Brodoff2
1Mitchell Hamline School of Law, Saint Paul, Minnesota, USA.
Journal of the American Geriatrics Society
|February 5, 2024
Summary
Patients with dementia may now access medical aid in dying (MAID) by using voluntarily stopping eating and drinking (VSED) to meet eligibility requirements. This approach offers a potential pathway for end-of-life choice previously unavailable to them.
Area of Science:
- Medical Ethics
- Neurology
- Palliative Care
Background:
- Dementia patients often desire medical aid in dying (MAID) before capacity loss.
- Existing MAID laws present eligibility barriers for dementia patients (capacity, self-administration, terminal status).
Purpose of the Study:
- To explore the potential for dementia patients to access MAID.
- To examine the role of voluntarily stopping eating and drinking (VSED) as a bridge to MAID.
- To provide clinical guidance on supporting dementia patients pursuing MAID.
Main Methods:
- Case study analysis of an Oregon patient with early-stage Alzheimer's using VSED for MAID.
- Discussion of historical barriers to VSED as a MAID pathway for dementia.
- Review of recent legal changes impacting MAID eligibility for dementia.
Main Results:
- A case demonstrates successful use of VSED to meet MAID eligibility criteria for an early-stage dementia patient.
- Recent legal amendments and VSED strategies may overcome prior exclusions.
- This combined approach presents a new possibility for end-of-life care in dementia.
Conclusions:
- The exclusion of dementia patients from MAID may be reconsidered.
- VSED can potentially serve as a bridge to MAID for individuals with dementia.
- Further clinical guidance is needed to support this evolving end-of-life care option.
More Related Videos
Related Concept Videos
Alzheimer's Disease: Treatment
193
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
193
Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
Ethical Dilemmas II
1.1K
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
1.1K
Alzheimer's Disease: Overview
487
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
487
Continuing Care
1.5K
Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
Aging
51
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
51

